CLINICAL TRIALS PROFILE FOR PRAMLINTIDE ACETATE
✉ Email this page to a colleague
All Clinical Trials for pramlintide acetate
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00042458 ↗ | Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control | Completed | AstraZeneca | Phase 3 | 2002-04-01 | This is a randomized, triple-blind, placebo-controlled, multicenter study to investigate the safety of pramlintide treatment using pramlintide dose-titration coupled with insulin adjustments in subjects with type 1 diabetes who are actively trying to improve their glycemic control. |
NCT00042471 ↗ | Evaluation of the Bioavailability of Pramlintide | Completed | AstraZeneca | Phase 2 | 2002-06-01 | This is a randomized, open-label, crossover study to examine the bioavailability of pramlintide in normal weight and overweight subjects with type 1 and type 2 diabetes mellitus using insulin. |
NCT00042601 ↗ | Evaluation of the Effect of Pramlintide on Satiety and Food Intake | Completed | AstraZeneca | Phase 2 | 2002-07-01 | This is a single center, randomized, blinded, placebo-controlled, two-period, cross-over study to evaluate the effect of pramlintide on satiety and food intake in normal-weight and obese non-diabetic subjects and in insulin-treated subjects with type 1 and type 2 diabetes. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for pramlintide acetate
Condition Name
Clinical Trial Locations for pramlintide acetate
Trials by Country
Clinical Trial Progress for pramlintide acetate
Clinical Trial Phase
Clinical Trial Sponsors for pramlintide acetate
Sponsor Name